Commvault Welcomes Industry Veteran Ha Hoang as New Chief Information Officer
Hoang’s business transformation and cloud solutions expertise to help drive Commvault’s growth strategy in cyber resilience TINTON FALLS, N.J., March... Read more.
Clinch Introduces First-to-Market Dynamic Font Feature and Automated Subtitles to Eliminate Bottlenecks in Multilingual Ad Creative
New Automated Creative Authoring Capabilities Bring Massive Efficiencies to the Process of Building and Scaling Global Ad Campaigns NEW YORK, March 4, 2025 /PRNewswire/... Read more.
GEM HEALTH Secures $7 Million Series A to Scale Transformative Virtual Sleep Care
GEM HEALTH is a nationwide virtual specialty clinic providing timely, convenient, and insurance-accessible specialty sleep care services GEM SLEEP provides a focused... Read more.
Lucid Diagnostics Announces $15.3 Million Registered Direct Offering
NEW YORK, March 4, 2025 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer... Read more.
Jagex announces CEO Transition
Jon Bellamy appointed as CEO CAMBRIDGE, England, March 4, 2025 /PRNewswire/ — Jagex, a leading UK video game company and developer of the RuneScape MMORPG... Read more.
ChannelEngine Welcomes Bart Verschoor as new Chief Operating Officer
LEIDEN, The Netherlands, March 4, 2025 /PRNewswire/ — ChannelEngine, a leading marketplace integration and management platform, is further strengthening its... Read more.
New Gold Announces Tender Offer for its 7.50% Senior Notes due 2027
(All amounts are in U.S. dollars unless otherwise indicated) TORONTO, March 4, 2025 /PRNewswire/ – New Gold Inc. (“New Gold” or the “Company”)... Read more.
PSI Enhances Test Center Network with Key Investments, Reducing Support Calls by 40%
OLATHE, Kan., March 4, 2025 /PRNewswire/ — PSI Services has begun a large investment program to further enhance its already high-performing U.S. Test Center... Read more.
Hoth Therapeutics Announces Positive Findings on GDNF’s Potential as a Game-Changer in Obesity Treatment and Reduced Fatty Liver Disease
Research Demonstrates GDNF’s Ability to Prevent and Reverse Obesity by Enhancing Fat Metabolism and Energy Expenditure Hoth is developing this therapeutic in... Read more.
Genprex to Participate at BIO Europe Spring 2025
AUSTIN, Texas, March 4, 2025 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy... Read more.